Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gudang Garam Tbk. (GGRM) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Gudang Garam Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Gudang Garam Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Gudang Garam Tbk. trades at Rp20,025 (market cap 37.66T, 1.7M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Gudang Garam Tbk. is far larger — about 3× Tempo Scan Pacific Tbk.'s market cap, and Gudang Garam Tbk. is more actively traded (1.7M versus 235.2K). Which is the better fit depends on your goals.

GGRMTSPC
Market Cap
37.66T12.58T
Volume
1.7M235.2K
Lot
17.03K2.35K
Turnover
34.27B649.94M
Average Price
20,122.932,763.37
Value
34.27B649.94M
Indicative Equilibrium Price
20,0252,780
Indicative Equilibrium Volume
3589

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GGRM
View details
TSPC
View details

About Gudang Garam Tbk.

PT Gudang Garam Tbk (the Company), previously named as PT Perusahaan Rokok Tjap Gudang Garam Kediri was established by Deed of Mr. Suroso S.H., acting notary public in Kediri, dated 30 June 1971 No. 10 amended by deed of the same notary dated 13 October 1971 No. 13. The Company is a continuation of a Proprietorship which was established in 1958. In 1969, the Company changed its legal status to a Partnership and in 1971 it was further changed its legal entity as a Limited Liability Company. Commercial operation was commenced in 1958.

Read more on GGRM

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC